Using Cranial Electrotherapy Stimulation to Improve Thinking, Anxiety, Depression, and Sleep in Adults with Chronic Mental Illness

What this Trial Is About

This research aims to explore the use of cranial electrotherapy stimulation CES to improve cognition, anxiety, depression, sleep, and overall quality of life in patients with chronic mental illness living in nursing homes. These residents often face loneliness, depression, and anxiety, and there is limited research on how CES might affect their cognitive status. The study is an interventional trial conducted with participants who meet specific cognitive and educational criteria. Participants are randomly assigned to either an experimental group receiving CES or a control group with no intervention. The experimental group undergoes CES five times a week, each session lasting 40 minutes, for a total of 12 weeks. Before starting, participants complete a questionnaire, then again after the intervention and once more after a three-month follow-up period. If any discomfort such as dizziness or skin irritation occurs during CES, the treatment is stopped immediately for evaluation and care. During the study, participants will complete questionnaires to assess sleep quality, depression, cognition, and anxiety from enrollment through the 12-week treatment period. Researchers will monitor these outcomes to understand the effects of CES on these conditions. Personal data is kept confidential and coded for privacy. Participants who complete the data collection will receive a gift voucher. The total duration includes the treatment and follow-up assessments extending beyond the 12-week intervention.

The Effect of Cranial Electrotherapy Stimulation on the Cognition, Anxiety, Depression and Sleep Quality of Chronic Psychiatric Patients